Sanofi - Q3 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Sanofi (SNY) Reports Q3 EPS of EUR1.25
October 29, 2015 6:18 AM EDTSanofi (NYSE: SNY) reported Q3 EPS of EUR1.25, versus EUR0.91 reported last year. Revenue for the quarter came in at EUR9.59 million, versus EUR8.78 million reported last year.
Broad-based sales growth despite Diabetes sales erosion in the U.S.
